All products / DC8507
AG13958
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $750 USDRequest a quote / confirm availability → |
| 250 mg | $1,200 USDRequest a quote / confirm availability → |
| 1 g | $2,600 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
AG13958 is a VEGF inhibitor that was clinical development by Pfizer in 2006-07 for treatment of age-related macular degeneration (AMD). The drug displays low water solubility and so far in trials delivery has been difficult needing direct injection to be truly effective and it varied by the species used because of species specific differences in eye circulation and vascularization. As a VEGF inhibitor AG13958 was targeted to FLT/TYK receptor inhibition.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC8507 |
|---|---|
| Product name | AG13958 |
| CAS | 319460-94-1 |
| Molecular formula | C26H22FN7O |
| Molecular weight | 467.497 |
| Purity | >98% |
| SMILES | Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — AG13958 (DC8507)